tirzepatide nombre comercial en argentina La nueva inyección probada España que promete revolucionar la forma de adelgazar Para qué sirve el Tirzepatida,

Very few documented cases exist, and none in published clinical trials

Recent anecdotal reports have raised concern that delayed gastric emptying associated with GLP-1 receptor agonists can increase the incidence of regurgitation and subsequent aspiration of stomach contents during general anesthesia and deep sedation resulting in serious lung injury

Specifically for stomach (GI) issues, stopping due to GI side effects were at: Over the longest studies so far which were up to 3 years, researchers havent found any long-term side effects or problems beyond what we already know, mostly stomach related

In the landmark STEP trial, semaglutide produced an average 14.9% body-weight reduction over 68 weeks